Latest filing published 23 Aug 2018 for NextCell Pharma AB.
Insider track record
BioAll AB: trading record in brief
All filings by BioAll AB on record concern NextCell Pharma AB. In total, 4 filings cover trades dated from 22 June 2017 to 23 August 2018.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 23 August 2018, the filings show a transaction in NextCell Pharma AB. Filings reach the Finansinspektionen feed a median of 8 days after the trade. The legal deadline for notifying a trade is three business days (MAR article 19). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to BioAll AB
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 19,200 shares0ISIN SE0009888795FI:csv-fdfedf4c8616a3fda0c7
- 19,200 shares@ SEK 5.0042.5% of flowISIN SE0009723125FI:csv-37ff8f54fb5fd02e627c
- 20,000 shares0ISIN SE0009888795FI:csv-29cb348f8d581f8b9814
- 24,000 shares@ SEK 5.0057.5% of flowISIN SE0009723125FI:csv-613d9d3ea08270729185
4 of 4 declarations